跳至主要内容
临床试验/NCT02891031
NCT02891031Unknown不适用

The Effects of Rhus Coriaria L. on Serum Uric Acid Levels

Shiraz University of Medical Sciences1 个研究点 分布在 1 个国家目标入组 76 人开始时间: 2019年6月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
76
试验地点
1
主要终点
serum uric acid levels

研究概览

简要总结

The aim of this study is to evaluate the effects of Rhus coriaria L. (Rhus) commonly known as "Somagh" on serum uric acid levels.

详细描述

Rhus coriaria L.(Rhus) is a well-known spice widely consumed in the world which has also been utilized extensively for medicinal purposes. The antioxidant components of this plant made it a favorable target for laboratory and animal studies in different conditions such as oxidative stress cytotoxicity, diabetes and hyperlipidemia. Rhus (Somagh) is found in temperate and tropical regions worldwide, often growing in areas of marginal agricultural capacity. Rhus is used as an herbal remedy in traditional medicine because of its assumed analgesic, antidiarrheic, antiseptic, anorexic and antihyperglycemic properties. The fruits of Rhus contain flavonols, phenolic acids, hydrolysable tannins, anthocyans and organic acids such as malice, citric and tartaric acids. Some studies have shown that polyphenols could have beneficial effects on cardiovascular disease and cancer and could be regarded as bioactive compounds with a high potential health-promoting capacity. Phenolic compounds inhibit lipid peroxidation, scavenge the superoxide anion and hydroxyl radical, and enhance the activities of detoxifying enzymes.

Uric acid (UA; 7,9-dihydro-1H-purine-2,6,8(3H)-trione) has been implicated as a risk factor and cause of numerous disease states. Some disease states, such as gout, hypertension, and cardiovascular disease, have been shown to result when UA levels in the blood are too high. Hyperuricemia predicts the development of hypertension in the general population, and an independent positive correlation between UA levels and the occurrence of hypertension has been reported. Hyperuricemia may also be a risk factor for cardiovascular disease, myocardial infarction, and stroke.

The manipulation of serum UA levels has become a popular strategy in the treatment of a variety of diseases. This is either accomplished through dietary and lifestyle changes or through treatment with UA reducing drugs.

The aim of this study is to evaluate the effects of Rhus coriaria L. (Rhus) commonly known as Somagh on serum uric acid levels.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy individuals

排除标准

  • Serum uric acid levels that need medical treatment
  • Diabetes mellitus
  • Hypo. or hyperthyroidism
  • Any systemic illnesses e.g. liver cirrhosis, acute or chronic renal failure, heart failure
  • Use of drugs: Uric acid lowering agents
  • Pregnancy
  • Lactation
  • History of allergic reaction to Somagh

研究组 & 干预措施

Rhus (Somagh)

Active Comparator

500 mg twice daily after meal for 6 weeks

干预措施: Rhus (Somagh) (Drug)

Placebo

Placebo Comparator

500 mg twice daily after meal for 6 weeks

干预措施: Placebo (Drug)

结局指标

主要结局

serum uric acid levels

时间窗: 6 weeks

次要结局

  • Number of patients with adverse events.(6 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mesbah Shams, MD

Associate professor of Internal medicine and Endocrinology

Shiraz University of Medical Sciences

研究点 (1)

Loading locations...

相似试验